Neurophysiological and therapeutic efficacy of somatic psychotherapies in addiction: primary behavioral focus with exploratory cross-addiction analyses.

J Addict DisOct 8, 2025 (epub)
Clinical ResearchPsychiatry

Christopher Lomas

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and random-effects meta-analysis examined somatic and body-oriented psychotherapies—including yoga, mindfulness, and somatic interventions—for gambling, gaming, or compulsive sexual behavior. It included nine randomized controlled trials with 573 participants. The pooled effect indicated symptom reduction (Hedges’ g = -2.62, 95% CI [-4.73, -0.51], p = .015), but heterogeneity was substantial (I² = 95.6%). The direction of effect persisted in sensitivity analyses, and no serious adverse events were reported. The authors describe the findings as short-term and propose these approaches as adjuncts, while calling for further trials.

Key findings

  • Across nine randomized trials (N = 573), the pooled effect was g = -2.62, 95% CI [-4.73, -0.51], p = .015.
  • Heterogeneity was substantial (I² = 95.6%), although the direction of effect persisted in sensitivity analyses.
  • No serious adverse events were reported.

Why it matters

The synthesis suggests that body-oriented approaches may reduce symptoms across several behavioral addictions and could complement existing care. However, the marked variation among trial results makes the pooled estimate uncertain as a guide to expected benefit. The proposed autonomic and interoceptive mechanisms remain preliminary, underscoring the need to assess mechanisms and durability rather than infer them from symptom outcomes alone.

What to keep in mind

The evidence base comprised nine trials, with substantial heterogeneity (I² = 95.6%). The authors characterize the symptom reduction as short-term and call for longer follow-up and trials that isolate active components.

Source

Published in J Addict Dis. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.